MicroPort Scientific Corporation

853 KYG608371046

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 09:08:03 11/07/2025 BST			5-day change	1st Jan Change
8.600 ^HKD	+3.24%		-7.73%	+34.59%

06-30	MicroPort NeuroTech Grants License to Majority Shareholder to Commercialize Medical Devices Overseas; MicroPort NeuroTech Shares Gain 5%	MT
06-30	MicroPort Scientific Appoints Co-CEO, Chief Medical Officer; Shares Gain 2%	MT

MicroPort MedBot, Controlling Shareholder to Sell Shares; Shares Fall 7%

Published on 14/05/2025 at 03:51

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about MicroPort Scientific Corporation

MicroPort NeuroTech Grants License to Majority Shareholder to Commercialize Medical Devices Overseas; MicroPort NeuroTech Shares Gain 5%	06-30	MT
MicroPort Scientific Appoints Co-CEO, Chief Medical Officer; Shares Gain 2%	06-30	MT
MicroPort NeuroScientific Corporation Enters into Master Distribution Agreement with MicroPort Scientific Corporation	06-27	CI
MicroPort MedBot, Controlling Shareholder to Sell Shares; Shares Fall 7%	05-14	MT
Microport Scientific Says Shanghai Medbot To Place Maximum Of 25.1 Million Placing Shares	05-14	RE
Shanghai Fund in Talks to Buy Otsuka's 20.9% Stake in MicroPort	05-02	MT
Shanghai Fund Is Said to Weigh Buying Otsuka?s Stake in MicroPort	04-30	CI
Microport Scientific Posts Qtrly Revenue RMB332.2 Million For Shanghai Microport Endovascular Medtech	04-29	RE
MicroPort Scientific Corporation Auditor Raises 'Going Concern' Doubt	04-28	CI
MicroPort Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	03-28	CI
Nomura Adjusts MicroPort Scientific's Price Target to HK$7.73 From HK$6.71, Keeps at Neutral	03-11	MT
MicroPort Scientific Expects 58% Lower Loss in 2024	03-10	MT
Microport Scientific Sees FY Net Loss Of No More Than $275 Million	03-07	RE
MicroPort Scientific's Subsidiary Expects to Book Up to 9.86% Higher Attributable Net Profit for 2024	01-21	MT
Shanghai MicroPort MedBot Renews Contracts with Affiliate	01-20	MT
Microport Scientific Corporation Announces Changes to Its Principal Place of Business	01-12	CI
Otsuka Reportedly to Considers Options for Its Stakes in MicroPort Scientific	16/10/24	CI
MicroPort Scientific Shrinks Loss by 41% in H1	27/09/24	MT
MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2024	30/08/24	CI
MicroPort CardioFlow Medtech to Buy Industrial Site from MicroPort Medical	23/08/24	MT
Chinese Regulator Approves MicroPort Scientific's Firesorb Stent for Marketing	31/07/24	MT
MicroPort Scientific Corporation Announces Firesorb Bioresorbable Coronary Scaffold System Obtained Approval for Marketing from the NMPA	30/07/24	CI
MicroPort Scientific Forecasts Up to 52% Decline in H1 Net Loss; Shares Rise 4%	26/07/24	MT
MicroPort Scientific Corporation Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2024	25/07/24	CI
MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue	09/07/24	MT

Chart MicroPort Scientific Corporation

Duration

Period

853: Dynamic Chart

MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.

Employees

6,347

Sector

Advanced Medical Equipment & Technology

Calendar

08-26 - Q2 2025 Earnings Release (Projected)

More about the company